Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
8.10
-0.25 (-2.99%)
Sep 8, 2026, 3:36 PM EDT - Market open
Sight Sciences Employees
Sight Sciences had 186 employees as of December 31, 2025. The number of employees decreased by 30 or -13.89% compared to the previous year.
Employees
186
Change (1Y)
-30
Growth (1Y)
-13.89%
Revenue / Employee
$448,263
Profits / Employee
-$159,984
Market Cap
446.21M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 186 | -30 | -13.89% |
| Dec 31, 2024 | 216 | 2 | 0.93% |
| Dec 31, 2023 | 214 | -36 | -14.40% |
| Dec 31, 2022 | 250 | 38 | 17.92% |
| Dec 31, 2021 | 212 | 43 | 25.44% |
| Mar 31, 2021 | 169 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Tactile Systems Technology | 1,086 |
| Pacific Biosciences of California | 485 |
| Cerus | 275 |
| NeuroPace | 220 |
| ClearPoint Neuro | 172 |
| 908 Devices | 172 |
| Senseonics Holdings | 130 |
SGHT News
- 6 days ago - Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15 - GlobeNewsWire
- 20 days ago - Sight Sciences announces updated TearCare System Indications for Use - TheFly
- 20 days ago - TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease - GlobeNewsWire
- 22 days ago - Sight Sciences price target raised to $8 from $6 at Citi - TheFly
- 4 weeks ago - Sight Sciences price target raised to $8 from $7 at UBS - TheFly
- 4 weeks ago - Sight Sciences reports Q2 EPS (8c), consensus (14c) - TheFly
- 4 weeks ago - Sight Sciences raises FY26 revenue view to $88M-$92M from $83M-$89M - TheFly
- 4 weeks ago - Sight Sciences Earnings Call Transcript: Q2 2026 - Transcripts